Perhaps unsurprising, the PTCL subtypes characterized by the T follicular phenotype and defined by hallmark mutations in epigenetic regulators, namely AITL and PTCL-TFH, have been shown to more responsive to HDAC inhibition. This evidence concerns the gene HDAC9 and mature T-cell and NK-cell non-Hodgkin lymphoma.